UniSuper Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
UniSuper Management's ABBV Position: Q3 2026 in Review
UniSuper Management increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $22.2M and bringing the position to 456,240 shares worth $119M. The position accounts for 0.59% of the portfolio, ranked #28.
UniSuper Management first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. 2,769 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- UniSuper Management held 456,240 shares of AbbVie worth $119M as of Q3 2026.
- UniSuper Management bought 86,423 AbbVie shares in Q3 2026, an estimated $22.2M.
- AbbVie made up 0.59% of UniSuper Management's portfolio in Q3 2026, its #28 holding.
- UniSuper Management first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
- 2,769 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.